-
1 Comment
Summerway Capital Plc is currently in a long term uptrend where the price is trading 3.9% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Its net income has dropped by 0.0% to $-38K since the same quarter in the previous year.
Finally, its free cash flow grew by 34.1% to $-30K since the same quarter in the previous year.
Based on the above factors, Summerway Capital Plc gets an overall score of 3/5.
Exchange | LSE |
---|---|
CurrencyCode | GBP |
ISIN | GB00BDQYGP38 |
Sector | Financial Services |
Industry | Asset Management |
Market Cap | 91M |
---|---|
PE Ratio | None |
Target Price | None |
Dividend Yield | 0.0% |
Beta | 1.06 |
Summerway Capital Plc is a private equity firm specializing in acquisition and buyout opportunities. It prefers to invest in healthcare and pharmaceutical sectors. It typically invests between £5 million ($6.51 million) to a maximum of £100 million ($130.29 million) in size and it also consider transactions in excess of £100 million ($130.29 million). It prefers to take majority stakes. Summerway Capital Plc was founded in 2018 and is based in London, United Kingdom with an additional office in Leeds, United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SWC.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025